The global Allergic Conjunctivitis Drugs market size was valued at US$ 2.89 billion in 2024 and is projected to reach US$ 3.78 billion by 2030, at a CAGR of 4.6% during the forecast period 2024-2030. United States Allergic Conjunctivitis Drugs market size was valued at US$ 989 million in 2024 and is projected to reach US$ 1.26 billion by 2030, at a CAGR of 4.1% during the forecast period 2024..
